LymphedemaV1, PubMed, Corpus, bibRecord, 001B10

The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.

Identifieur interne : 001B10 ( PubMed/Corpus ); précédent : 001B09; suivant : 001B11

The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.

Auteurs : Alex P. Keim ; Justin R. Slis ; Uziel Mendez ; Emily M. Stroup ; Yvonne Burmeister ; Natalie Tsolaki ; Oliver Gailing ; Jeremy Goldman

Source :

Lymphatic research and biology [ 1557-8585 ] ; 2013.

RBID : pubmed:23725444

English descriptors

KwdEn :
- Animals, Disease Models, Animal, Female, Lymphedema (drug therapy), Lymphedema (pathology), Macrophages (pathology), Mice, Mice, Inbred BALB C, Plant Extracts (therapeutic use), Wound Healing.
MESH :
- chemical , therapeutic use : Plant Extracts.
- drug therapy : Lymphedema.
- pathology : Lymphedema, Macrophages.
- Animals, Disease Models, Animal, Female, Mice, Mice, Inbred BALB C, Wound Healing.

Abstract

Secondary lymphedema is a life-long disease of painful tissue swelling that often follows axillary lymph node dissection to treat breast cancer. It is hypothesized that poor lymphatic regeneration across the obstructive scar tissue during the wound healing process may predispose the tissue to swell at a later date. Treatment for lymphedema remains suboptimal and is in most cases palliative. The purpose of this study was to evaluate the ability of Lymphomyosot to treat tissue swelling and promote lymphangiogenesis in experimental models of murine lymphedema.

DOI: 10.1089/lrb.2012.0024
PubMed: 23725444

Links to Exploration step

pubmed:23725444

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.</title>
<author><name sortKey="Keim, Alex P" sort="Keim, Alex P" uniqKey="Keim A" first="Alex P" last="Keim">Alex P. Keim</name>
<affiliation><nlm:affiliation>Department of Biomedical Engineering, Michigan Technological University, Houghton, Michigan, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Slis, Justin R" sort="Slis, Justin R" uniqKey="Slis J" first="Justin R" last="Slis">Justin R. Slis</name>
</author>
<author><name sortKey="Mendez, Uziel" sort="Mendez, Uziel" uniqKey="Mendez U" first="Uziel" last="Mendez">Uziel Mendez</name>
</author>
<author><name sortKey="Stroup, Emily M" sort="Stroup, Emily M" uniqKey="Stroup E" first="Emily M" last="Stroup">Emily M. Stroup</name>
</author>
<author><name sortKey="Burmeister, Yvonne" sort="Burmeister, Yvonne" uniqKey="Burmeister Y" first="Yvonne" last="Burmeister">Yvonne Burmeister</name>
</author>
<author><name sortKey="Tsolaki, Natalie" sort="Tsolaki, Natalie" uniqKey="Tsolaki N" first="Natalie" last="Tsolaki">Natalie Tsolaki</name>
</author>
<author><name sortKey="Gailing, Oliver" sort="Gailing, Oliver" uniqKey="Gailing O" first="Oliver" last="Gailing">Oliver Gailing</name>
</author>
<author><name sortKey="Goldman, Jeremy" sort="Goldman, Jeremy" uniqKey="Goldman J" first="Jeremy" last="Goldman">Jeremy Goldman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23725444</idno>
<idno type="pmid">23725444</idno>
<idno type="doi">10.1089/lrb.2012.0024</idno>
<idno type="wicri:Area/PubMed/Corpus">001B10</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B10</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.</title>
<author><name sortKey="Keim, Alex P" sort="Keim, Alex P" uniqKey="Keim A" first="Alex P" last="Keim">Alex P. Keim</name>
<affiliation><nlm:affiliation>Department of Biomedical Engineering, Michigan Technological University, Houghton, Michigan, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Slis, Justin R" sort="Slis, Justin R" uniqKey="Slis J" first="Justin R" last="Slis">Justin R. Slis</name>
</author>
<author><name sortKey="Mendez, Uziel" sort="Mendez, Uziel" uniqKey="Mendez U" first="Uziel" last="Mendez">Uziel Mendez</name>
</author>
<author><name sortKey="Stroup, Emily M" sort="Stroup, Emily M" uniqKey="Stroup E" first="Emily M" last="Stroup">Emily M. Stroup</name>
</author>
<author><name sortKey="Burmeister, Yvonne" sort="Burmeister, Yvonne" uniqKey="Burmeister Y" first="Yvonne" last="Burmeister">Yvonne Burmeister</name>
</author>
<author><name sortKey="Tsolaki, Natalie" sort="Tsolaki, Natalie" uniqKey="Tsolaki N" first="Natalie" last="Tsolaki">Natalie Tsolaki</name>
</author>
<author><name sortKey="Gailing, Oliver" sort="Gailing, Oliver" uniqKey="Gailing O" first="Oliver" last="Gailing">Oliver Gailing</name>
</author>
<author><name sortKey="Goldman, Jeremy" sort="Goldman, Jeremy" uniqKey="Goldman J" first="Jeremy" last="Goldman">Jeremy Goldman</name>
</author>
</analytic>
<series><title level="j">Lymphatic research and biology</title>
<idno type="eISSN">1557-8585</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Lymphedema (drug therapy)</term>
<term>Lymphedema (pathology)</term>
<term>Macrophages (pathology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Plant Extracts (therapeutic use)</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymphedema</term>
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Wound Healing</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Secondary lymphedema is a life-long disease of painful tissue swelling that often follows axillary lymph node dissection to treat breast cancer. It is hypothesized that poor lymphatic regeneration across the obstructive scar tissue during the wound healing process may predispose the tissue to swell at a later date. Treatment for lymphedema remains suboptimal and is in most cases palliative. The purpose of this study was to evaluate the ability of Lymphomyosot to treat tissue swelling and promote lymphangiogenesis in experimental models of murine lymphedema.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23725444</PMID>
<DateCreated><Year>2013</Year>
<Month>06</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>01</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8585</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>11</Volume>
<Issue>2</Issue>
<PubDate><Year>2013</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Lymphatic research and biology</Title>
<ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.</ArticleTitle>
<Pagination><MedlinePgn>81-92</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1089/lrb.2012.0024</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Secondary lymphedema is a life-long disease of painful tissue swelling that often follows axillary lymph node dissection to treat breast cancer. It is hypothesized that poor lymphatic regeneration across the obstructive scar tissue during the wound healing process may predispose the tissue to swell at a later date. Treatment for lymphedema remains suboptimal and is in most cases palliative. The purpose of this study was to evaluate the ability of Lymphomyosot to treat tissue swelling and promote lymphangiogenesis in experimental models of murine lymphedema.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Experimental models of mouse lymphedema were injected with varied amounts of Lymphomyosot and saline as control. Measurements of tail swelling and wound closure were taken and compared amongst the groups. Three separate groups of mice were analyzed for lymphatic capillary migration, lymphatic vessel regeneration, and macrophage recruitment.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Lymphomyosot significantly reduced swelling and increased the rate of surgical wound closure. Lymphomyosot did not increase the migration of lymph capillaries in a mouse tail skin regeneration model or regeneration of lymph vessels following murine axillary lymph node dissection.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Lymphomyosot may act through inflammatory and wound repair pathways to reduce experimental lymphedema. Its ability to regulate inflammation as well as assist in tissue repair and extracellular formation may allow for the production of a scar-free matrix bridge through which migrating cells and accumulated interstitial fluid can freely spread.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keim</LastName>
<ForeName>Alex P</ForeName>
<Initials>AP</Initials>
<AffiliationInfo><Affiliation>Department of Biomedical Engineering, Michigan Technological University, Houghton, Michigan, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Slis</LastName>
<ForeName>Justin R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mendez</LastName>
<ForeName>Uziel</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y"><LastName>Stroup</LastName>
<ForeName>Emily M</ForeName>
<Initials>EM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Burmeister</LastName>
<ForeName>Yvonne</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tsolaki</LastName>
<ForeName>Natalie</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gailing</LastName>
<ForeName>Oliver</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Goldman</LastName>
<ForeName>Jeremy</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>06</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Lymphat Res Biol</MedlineTA>
<NlmUniqueID>101163587</NlmUniqueID>
<ISSNLinking>1539-6851</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C518246">Lymphomyosot</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2007 Sep;40(3):122-6</RefSource>
<PMID Version="1">18062613</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2000 Nov;6(6):373-378</RefSource>
<PMID Version="1">11348395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2004 Sep 1;64(17):6337-43</RefSource>
<PMID Version="1">15342423</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacol Res. 2006 Mar;53(3):233-40</RefSource>
<PMID Version="1">16406805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2005 Dec;6(12):1191-7</RefSource>
<PMID Version="1">16369558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2176-83</RefSource>
<PMID Version="1">17189348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2007;5(4):219-31</RefSource>
<PMID Version="1">18370912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Korean J Physiol Pharmacol. 2008 Dec;12(6):343-7</RefSource>
<PMID Version="1">19967077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Endocr Rev. 2012 Jun;33(3):378-455</RefSource>
<PMID Version="1">22419778</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1326-34</RefSource>
<PMID Version="1">18203849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2007 Jun;14(6):1904-8</RefSource>
<PMID Version="1">17342565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Pharmacol. 2010 Jun 10;635(1-3):79-86</RefSource>
<PMID Version="1">20338162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1402-10</RefSource>
<PMID Version="1">16648194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 2001 Jun;22(6):285-91</RefSource>
<PMID Version="1">11395156</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Surg. 2011 Oct;213(4):543-51</RefSource>
<PMID Version="1">21802319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2010 Dec;10(12):826-37</RefSource>
<PMID Version="1">21088683</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Oral Pathol Med. 2009 Mar;38(3):276-81</RefSource>
<PMID Version="1">19267840</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nonlinearity Biol Toxicol Med. 2005 Jan;3(1):9-21</RefSource>
<PMID Version="1">19330154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Sci Total Environ. 2013 Jan 15;443:573-81</RefSource>
<PMID Version="1">23220391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Phytother Res. 2010 Sep;24(9):1365-9</RefSource>
<PMID Version="1">20812280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2007 Apr;21(4):1003-12</RefSource>
<PMID Version="1">17210781</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 2011 Mar 10;176:408-19</RefSource>
<PMID Version="1">21168474</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2012 Sep;10(3):122-8</RefSource>
<PMID Version="1">22984909</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biomech. 1999 Dec;32(12):1297-307</RefSource>
<PMID Version="1">10569708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2013 Feb;32(2):120-52</RefSource>
<PMID Version="1">23060412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int Immunopharmacol. 2008 Jul;8(7):1059-64</RefSource>
<PMID Version="1">18486919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Jan 5;97(1):14-21</RefSource>
<PMID Version="1">15632376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Phytother Res. 2008 Nov;22(11):1552-6</RefSource>
<PMID Version="1">18814209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2008 Jan 1;180(1):569-79</RefSource>
<PMID Version="1">18097059</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H46-54</RefSource>
<PMID Version="1">20207821</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Phytomedicine. 2011 May 15;18(7):617-24</RefSource>
<PMID Version="1">21036574</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2012 Jun 1;590(Pt 11):2677-91</RefSource>
<PMID Version="1">22451438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2003 Apr 18;92(7):801-8</RefSource>
<PMID Version="1">12623882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Microvasc Res. 2006 Nov;72(3):161-71</RefSource>
<PMID Version="1">16876204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Agric Food Chem. 2008 May 28;56(10):3863-8</RefSource>
<PMID Version="1">18444659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2007 May;127(5):1009-17</RefSource>
<PMID Version="1">17435786</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Planta Med. 2006 Mar;72(4):289-94</RefSource>
<PMID Version="1">16557467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Phytother Res. 2002 Feb;16(1):33-5</RefSource>
<PMID Version="1">11807962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 1981 Oct;11(10):805-15</RefSource>
<PMID Version="1">7308288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2009 Aug;124(2):438-50</RefSource>
<PMID Version="1">19644258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2006 Jul;145(1):101-7</RefSource>
<PMID Version="1">16792679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2003 Aug;24(18):3005-12</RefSource>
<PMID Version="1">12895572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Phytother Res. 2011 Apr;25(4):473-83</RefSource>
<PMID Version="1">21105177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>In Vivo. 2009 Nov-Dec;23(6):1017-20</RefSource>
<PMID Version="1">20023249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biol Pharm Bull. 2009 Jun;32(6):1118-21</RefSource>
<PMID Version="1">19483327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Toxicol. 2010 May-Jun;29(3):235-46</RefSource>
<PMID Version="1">20448256</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Osteoarthritis Cartilage. 2010 Jan;18(1):106-16</RefSource>
<PMID Version="1">19786147</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacol Res. 2008 Aug;58(2):112-6</RefSource>
<PMID Version="1">18723091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biol Pharm Bull. 2009 Aug;32(8):1371-7</RefSource>
<PMID Version="1">19652376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2007 Feb;21(2):325-32</RefSource>
<PMID Version="1">17267386</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Nutr. 1976 Apr;106(4):478-84</RefSource>
<PMID Version="1">1255267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1:E69-74</RefSource>
<PMID Version="1">20961308</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2007 Jan;170(1):188-202</RefSource>
<PMID Version="1">17200193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2005 Oct 5;24(19):3400-10</RefSource>
<PMID Version="1">16148944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Evid Based Complement Alternat Med. 2011;2011:215035</RefSource>
<PMID Version="1">20007260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pathophysiology. 2010 Sep;17(4):263-76</RefSource>
<PMID Version="1">19945830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 Apr 1;184(7):3964-77</RefSource>
<PMID Version="1">20176743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2007 Dec;13(12):1458-66</RefSource>
<PMID Version="1">18059280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Dec;1823(12):2157-67</RefSource>
<PMID Version="1">22940077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Nutr Food Res. 2010 Mar;54(3):388-95</RefSource>
<PMID Version="1">19885845</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Biochem Cell Biol. 2004 Jun;36(6):1031-7</RefSource>
<PMID Version="1">15094118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biol Pharm Bull. 2005 Jul;28(7):1244-8</RefSource>
<PMID Version="1">15997107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cytokine. 2002 Jun 7;18(5):252-9</RefSource>
<PMID Version="1">12161100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2010 Sep;299(3):C589-605</RefSource>
<PMID Version="1">20519446</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2004 Feb;34(2):565-75</RefSource>
<PMID Version="1">14768062</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiology. 2008 Mar;246(3):734-41</RefSource>
<PMID Version="1">18223125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2010 Mar;19(3):299-305</RefSource>
<PMID Version="1">19399782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2005 Jun 10;96(11):1193-9</RefSource>
<PMID Version="1">15890974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27</RefSource>
<PMID Version="1">18849330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Inflamm Res. 2003 Aug;52(8):334-40</RefSource>
<PMID Version="1">14504671</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2005 Nov 15;70(10):1497-505</RefSource>
<PMID Version="1">16188240</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2011 Apr 6;31(14):5294-9</RefSource>
<PMID Version="1">21471364</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Agric Food Chem. 2004 Dec 15;52(25):7532-40</RefSource>
<PMID Version="1">15675800</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Mar 19;140(6):871-82</RefSource>
<PMID Version="1">20303877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3109-18</RefSource>
<PMID Version="1">17307997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Pharmacol. 2009 Oct;158(4):936-46</RefSource>
<PMID Version="1">19845684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2009 Sep 15;122(Pt 18):3209-13</RefSource>
<PMID Version="1">19726630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2007 Apr 15;178(8):4854-64</RefSource>
<PMID Version="1">17404266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2008 May;8(5):349-61</RefSource>
<PMID Version="1">18437155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2008 Dec;8(12):958-69</RefSource>
<PMID Version="1">19029990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurosci Res. 2003 Dec 15;74(6):948-55</RefSource>
<PMID Version="1">14648601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2005 Oct 1;92(1):23-31</RefSource>
<PMID Version="1">16180231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Theor Biol. 2007 Feb 7;244(3):489-99</RefSource>
<PMID Version="1">17049945</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Nutr Food Res. 2010 Sep;54(9):1351-60</RefSource>
<PMID Version="1">20229527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Rehabilitation (Stuttg). 2007 Dec;46(6):340-8</RefSource>
<PMID Version="1">18188805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2001 Aug;62(2):330-8</RefSource>
<PMID Version="1">11452146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Nat Prod. 2005 Nov;68(11):1610-4</RefSource>
<PMID Version="1">16309308</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nutr Metab (Lond). 2009 Aug 14;6:33</RefSource>
<PMID Version="1">19678956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nitric Oxide. 2005 Jun;12(4):237-43</RefSource>
<PMID Version="1">15917216</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Behav Brain Res. 2013 Feb 1;238:36-43</RefSource>
<PMID Version="1">23018127</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Basic Clin Pharmacol Toxicol. 2010 Aug;107(2):650-5</RefSource>
<PMID Version="1">20406206</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3696932</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>1</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23725444</ArticleId>
<ArticleId IdType="doi">10.1089/lrb.2012.0024</ArticleId>
<ArticleId IdType="pmc">PMC3696932</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B10 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001B10 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:23725444
   |texte=   The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:23725444" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.

The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki